Expert Video - How objective and safe are clinical trials for ovarian cancer?
Gynecologic oncologist Dr. Scott Richard describes how clinical trials are designed to minimize risk and how you can learn about the benefits and risks before deciding to join a trial. Clinical trials must be approved by a group called an Institutional Review Board before volunteers can join. He discusses the role of a data safety monitoring board and talks about different ways that researchers, institutional review board members and others ensure the research is done objectively and watch for any side effects.
This educational activity has been developed by the National Ovarian Cancer Coalition in collaboration with Mechanisms in Medicine Inc.
This activity is supported by educational grants from: Alkermes plc, AstraZeneca Pharmaceuticals LP, Clovis Oncology, Inc., Eisai Inc., Genentech, GSK, ImmunoGen, Inc, Merck & Co, Inc., Novartis, Novocure Inc., Pfizer, Inc.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.